Propanc Biopharma PPCB
NASDAQ PPCB
$0.49 +0.00 (+0.02%)
As of: Oct 1, 2026 · 3:05 PM EDT

Propanc Biopharma (PPCB) Price to Book (2025 - 2026)

Updated

Propanc Biopharma's (PPCB) Price to Book came in at 0.18 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 84.9% from 1.18 a year earlier.

Analysis

Propanc Biopharma (PPCB) Price to Book (2025 - 2026) Analysis & Trends

Since fiscal Q3 2025, Propanc Biopharma has reported Price to Book for 5 quarters.

  • In prior fiscal years, Propanc Biopharma's Price to Book was 1.18 in FY2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Propanc Biopharma 550,617.42 550,617.42 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.18
Dec 31, 2025 0.69
Sep 30, 2025 1.52
Jun 30, 2025 1.18
Mar 31, 2025 1.32
API Access

Propanc Biopharma Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=PPCB&period=max&api_key=YOUR_API_KEY